Comment on "Biostatistical Considerations When Using RWD and RWE in Clinical Studies for Regulatory Purposes: A Landscape Assessment"

被引：2
|
作者：
Uemura, Yukari [1 ]
Shinozaki, Tomohiro [2 ]
Nomura, Shogo [3 ]
Shibata, Taro [4 ]
机构：
[1] Natl Ctr Global Hlth & Med, Clin Res Ctr, Dept Data Sci, Tokyo, Japan
[2] Tokyo Univ Sci, Dept Informat & Comp Technol, Tokyo, Japan
[3] Univ Tokyo, Dept Biostat & Bioinformat, Tokyo, Japan
[4] Natl Canc Ctr, Biostat Div, Ctr Res Adm & Support, Tokyo, Japan
来源：
STATISTICS IN BIOPHARMACEUTICAL RESEARCH | 2023年 / 15卷 / 01期
关键词：
D O I：
10.1080/19466315.2021.1974537
中图分类号：
Q [生物科学];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
引用
收藏
页码：20 / 22
页数：3
相关论文
共 8 条
  • [1] Biostatistical Considerations When Using RWD and RWE in Clinical Studies for Regulatory Purposes: A Landscape Assessment
    Levenson, Mark
    He, Weili
    Chen, Jie
    Fang, Yixin
    Faries, Douglas
    Goldstein, Benjamin A.
    Ho, Martin
    Lee, Kwan
    Mishra-Kalyani, Pallavi
    Rockhold, Frank
    Wang, Hongwei
    Zink, Richard C.
    STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2023, 15 (01): : 3 - 13
  • [2] Comment on "Biostatistical Considerations When Using RWD and RWE in Clinical Studies for Regulatory Purposes: A Landscape Assessment": Is Real-World Evidence Real?
    Chen, Chian
    Hsiao, Chin-Fu
    STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2023, 15 (01): : 18 - 19
  • [3] Some Biostatistical Considerations About Real-World Data and Evidence in Clinical Studies, Especially for Regulatory Purposes
    Campbell, Gregory
    STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2023, 15 (01): : 14 - 17
  • [4] PMDA Perspective on RWD/RWE Utilization for Regulatory Purposes Including Assessment on the Impacts of Regulatory Actions and Safety Risk of a Drug at Postmarketing Stage
    Kajiyama, Kazuhiro
    Komamine, Maki
    Horiuchi, Naoya
    Iguchi, Toyotaka
    Uyama, Yoshiaki
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 (09)
  • [5] BIOSTATISTICAL CONSIDERATIONS FOR QUALITY ASSESSMENT OF IMMUNOLOGICAL MEASUREMENTS USED IN CLINICAL AND LONGITUDINAL-STUDIES
    GELMAN, R
    EUDEY, L
    CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1989, 52 (01): : 28 - 37
  • [6] Practical considerations for navigating the regulatory landscape of non-clinical studies for clinical translation of radiopharmaceuticals
    Korde, Aruna
    Mikolajczak, Renata
    Kolenc, Petra
    Bouziotis, Penelope
    Westin, Hadis
    Lauritzen, Mette
    Koole, Michel
    Herth, Matthias Manfred
    Bardies, Manuel
    Martins, Andre F.
    Paulo, Antonio
    Lyashchenko, Serge K.
    Todde, Sergio
    Nag, Sangram
    Lamprou, Efthimis
    Abrunhosa, Antero
    Giammarile, Francesco
    Decristoforo, Clemens
    EJNMMI RADIOPHARMACY AND CHEMISTRY, 2022, 7 (01)
  • [7] Practical considerations for navigating the regulatory landscape of non-clinical studies for clinical translation of radiopharmaceuticals
    Aruna Korde
    Renata Mikolajczak
    Petra Kolenc
    Penelope Bouziotis
    Hadis Westin
    Mette Lauritzen
    Michel Koole
    Matthias Manfred Herth
    Manuel Bardiès
    Andre F. Martins
    Antonio Paulo
    Serge K. Lyashchenko
    Sergio Todde
    Sangram Nag
    Efthimis Lamprou
    Antero Abrunhosa
    Francesco Giammarile
    Clemens Decristoforo
    EJNMMI Radiopharmacy and Chemistry, 7
  • [8] Clinical considerations when using assessment tools to identify depression in older adults with mild cognitive impairment
    Lee, Allen Ting Chun
    Chiu, Helen Fung Kum
    Peisah, Carmelle
    INTERNATIONAL PSYCHOGERIATRICS, 2022, 34 (05) : 413 - 416
1